Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Snyder

Showing results (411-420 of 469) with videos related to

Pageof 47
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 28, 2013
Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attentionClaire F Snyder, Amanda L Blackford, Toru Okuyama, et al.
Journal of Pediatric and Adolescent Gynecology|December 26, 2015
The Enigma of Rapid Repeat Pregnancy: A Qualitative Study of Teen MothersK N Conroy, T G Engelhart, Y Martins, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1982
Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responsesM L Blank, E A Cress, T C Lee, et al.
The Biochemical Journal|November 24, 1999
Design of an adenosine phosphorylase by active-site modification of murine purine nucleoside phosphorylase. Enzyme kinetics and molecular dynamics simulation of Asn-243 and Lys-244 substitutions of purine nucleoside phosphorylaseJ T Maynes, W Yam, J P Jenuth, et al.
Cancer|August 25, 2010
How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?Claire F Snyder, Kevin D Frick, Amanda L Blackford, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 16, 2014
Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needsClaire F Snyder, Amanda L Blackford, Jonathan Sussman, et al.
Journal of Oncology Practice|July 3, 2014
When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trialClaire F Snyder, Joseph M Herman, Sharon M White, et al.
Metabolism: Clinical and Experimental|February 26, 2003
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal diseaseMatthew Eric Hyndman, Braden J Manns, Floyd F Snyder, et al.
JMIR Cancer|April 15, 2017
Comparing Web-Based Provider-Initiated and Patient-Initiated Survivorship Care Planning for Cancer Patients: A Randomized Controlled TrialKatherine Clegg Smith, Elliott Tolbert, Susan M Hannum, et al.
Journal of Cancer Survivorship : Research and Practice|May 10, 2011
Preventive care in prostate cancer patients: following diagnosis and for five-year survivorsClaire F Snyder, Kevin D Frick, Robert J Herbert, et al.
Pageof 47

Showing results (411-420 of 469) with videos related to

Sort By:
Pageof 47
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 28, 2013
Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attentionClaire F Snyder, Amanda L Blackford, Toru Okuyama, et al.
Journal of Pediatric and Adolescent Gynecology|December 26, 2015
The Enigma of Rapid Repeat Pregnancy: A Qualitative Study of Teen MothersK N Conroy, T G Engelhart, Y Martins, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1982
Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responsesM L Blank, E A Cress, T C Lee, et al.
The Biochemical Journal|November 24, 1999
Design of an adenosine phosphorylase by active-site modification of murine purine nucleoside phosphorylase. Enzyme kinetics and molecular dynamics simulation of Asn-243 and Lys-244 substitutions of purine nucleoside phosphorylaseJ T Maynes, W Yam, J P Jenuth, et al.
Cancer|August 25, 2010
How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?Claire F Snyder, Kevin D Frick, Amanda L Blackford, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 16, 2014
Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needsClaire F Snyder, Amanda L Blackford, Jonathan Sussman, et al.
Journal of Oncology Practice|July 3, 2014
When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trialClaire F Snyder, Joseph M Herman, Sharon M White, et al.
Metabolism: Clinical and Experimental|February 26, 2003
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal diseaseMatthew Eric Hyndman, Braden J Manns, Floyd F Snyder, et al.
JMIR Cancer|April 15, 2017
Comparing Web-Based Provider-Initiated and Patient-Initiated Survivorship Care Planning for Cancer Patients: A Randomized Controlled TrialKatherine Clegg Smith, Elliott Tolbert, Susan M Hannum, et al.
Journal of Cancer Survivorship : Research and Practice|May 10, 2011
Preventive care in prostate cancer patients: following diagnosis and for five-year survivorsClaire F Snyder, Kevin D Frick, Robert J Herbert, et al.
Pageof 47